{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T19:51:00Z","timestamp":1774554660190,"version":"3.50.1"},"reference-count":91,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001824","name":"Czech Science Foundation","doi-asserted-by":"publisher","award":["GACR 17-16169S"],"award-info":[{"award-number":["GACR 17-16169S"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007397","name":"Grant Agency of Charles University","doi-asserted-by":"publisher","award":["GAUK 324215\/C\/2015"],"award-info":[{"award-number":["GAUK 324215\/C\/2015"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007397","name":"Grant Agency of Charles University","doi-asserted-by":"publisher","award":["SVV\/2016\/260-293"],"award-info":[{"award-number":["SVV\/2016\/260-293"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]},{"name":"EFSA-CDN","award":["CZ.02.1.01\/0.0\/0.0\/16_019\/0000841"],"award-info":[{"award-number":["CZ.02.1.01\/0.0\/0.0\/16_019\/0000841"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.bcp.2019.01.024","type":"journal-article","created":{"date-parts":[[2019,2,2]],"date-time":"2019-02-02T00:50:50Z","timestamp":1549068650000},"page":"60-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Transport of ribavirin across the rat and human placental barrier: Roles of nucleoside and ATP-binding cassette drug efflux transporters"],"prefix":"10.1016","volume":"163","author":[{"given":"S.","family":"Karbanova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1313-306X","authenticated-orcid":false,"given":"L.","family":"Cerveny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Jiraskova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Karahoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2936-7212","authenticated-orcid":false,"given":"M.","family":"Ceckova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Ptackova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6712-097X","authenticated-orcid":false,"given":"F.","family":"Staud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.bcp.2019.01.024_b0005","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.3748\/wjg.v13.i17.2436","article-title":"Epidemiology of hepatitis C virus infection","volume":"13","author":"Alter","year":"2007","journal-title":"World J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.bcp.2019.01.024_b0010","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.26141","article-title":"Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence","volume":"57","author":"Hanafiah","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2019.01.024_b0015","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jix688","article-title":"Contribution of liver fibrosis and microbial translocation to immune activation in HIV and HCV","author":"Reid","year":"2018","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.bcp.2019.01.024_b0020","article-title":"EASL recommendations on treatment of hepatitis C 2018","year":"2018","journal-title":"J. Hepatol."},{"issue":"13","key":"10.1016\/j.bcp.2019.01.024_b0025","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1097\/QAD.0b013e3282703810","article-title":"HCV\/HIV co-infection, HCV viral load and mode of delivery: risk factors for mother-to-child transmission of hepatitis C virus?","volume":"21","author":"Marine-Barjoan","year":"2007","journal-title":"AIDS"},{"issue":"8","key":"10.1016\/j.bcp.2019.01.024_b0030","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1086\/512815","article-title":"Impact of maternal HIV coinfection on the vertical transmission of hepatitis C virus: a meta-analysis","volume":"44","author":"Polis","year":"2007","journal-title":"Clin. Infect. Dis."},{"issue":"6","key":"10.1016\/j.bcp.2019.01.024_b0035","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/cid\/ciu447","article-title":"Vertical transmission of hepatitis C virus: systematic review and meta-analysis","volume":"59","author":"Benova","year":"2014","journal-title":"Clin. Infect. Dis."},{"issue":"9","key":"10.1016\/j.bcp.2019.01.024_b0040","doi-asserted-by":"crossref","first-page":"643","DOI":"10.4254\/wjh.v6.i9.643","article-title":"Vertical transmission of hepatitis C virus: current knowledge and perspectives","volume":"6","author":"Yeung","year":"2014","journal-title":"World J. Hepatol."},{"issue":"4050","key":"10.1016\/j.bcp.2019.01.024_b0045","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1126\/science.177.4050.705","article-title":"Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide","volume":"177","author":"Sidwell","year":"1972","journal-title":"Science"},{"key":"10.1016\/j.bcp.2019.01.024_b0050","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jpba.2017.06.071","article-title":"Current antiviral drugs and their analysis in biological materials-Part I: Antivirals against respiratory and herpes viruses","volume":"147","author":"Novakova","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.bcp.2019.01.024_b0055","unstructured":"WHO, WHO Model List of Essential Medicines for Children. <http:\/\/www.who.int\/medicines\/publications\/essentialmedicines\/en\/>, 2018 (accessed 14-02-2018.2018)."},{"key":"10.1016\/j.bcp.2019.01.024_b0060","unstructured":"WHO, WHO Model List of Essential Medicines. <http:\/\/www.who.int\/medicines\/publications\/essentialmedicines\/en\/>, 2018 (accessed 14-02-2018.2018)."},{"key":"10.1016\/j.bcp.2019.01.024_b0065","unstructured":"FDA, Ribavirin Pregnancy Registry. <http:\/\/www.ribavirinpregnancyregistry.com\/>, 2005 (accessed 06.12.2016.)."},{"issue":"1","key":"10.1016\/j.bcp.2019.01.024_b0070","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.reprotox.2005.06.005","article-title":"Pregnancy outcome after exposure to injectable ribavirin during embryogenesis","volume":"21","author":"Rezvani","year":"2006","journal-title":"Reprod. Toxicol."},{"issue":"12","key":"10.1016\/j.bcp.2019.01.024_b0075","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s40264-017-0566-6","article-title":"The ribavirin pregnancy registry: an interim analysis of potential teratogenicity at the mid-point of enrollment","volume":"40","author":"Sinclair","year":"2017","journal-title":"Drug Saf."},{"issue":"1","key":"10.1016\/j.bcp.2019.01.024_b0080","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/clinids\/14.1.217","article-title":"Complications of measles during pregnancy","volume":"14","author":"Atmar","year":"1992","journal-title":"Clin. Infect. Dis."},{"issue":"7","key":"10.1016\/j.bcp.2019.01.024_b0085","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1111\/j.1572-0241.2001.03996.x","article-title":"Conception soon after discontinuing interferon\/ribavirin therapy: a successful outcome","volume":"96","author":"Mishkin","year":"2001","journal-title":"Am. J. Gastroenterol."},{"issue":"7","key":"10.1016\/j.bcp.2019.01.024_b0090","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1111\/j.1572-0241.2001.03997.x","article-title":"No evidence for mutagenic effects of ribavirin: report of two normal pregnancies","volume":"96","author":"Hegenbarth","year":"2001","journal-title":"Am. J. Gastroenterol."},{"issue":"Suppl 1","key":"10.1016\/j.bcp.2019.01.024_b0095","first-page":"67","article-title":"Safety of combination interferon alfa-2b\/ribavirin therapy in chronic hepatitis C-relapsed and treatment-naive patients","volume":"19","author":"Maddrey","year":"1999","journal-title":"Semin. Liver Dis."},{"issue":"1","key":"10.1016\/j.bcp.2019.01.024_b0100","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1177\/135965350300800110","article-title":"Paternal exposure to ribavirin: pregnancy and neonatal outcome","volume":"8","author":"De Santis","year":"2003","journal-title":"Antivir. Ther."},{"issue":"3\u20134","key":"10.1016\/j.bcp.2019.01.024_b0105","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.reprotox.2007.07.002","article-title":"Infant of 22 months of age with no anomalies born from a HCV- and HIV-infected mother under treatment with pegylated interferon, ribavirin and antiretroviral therapy during the first 16 weeks of pregnancy","volume":"24","author":"Labarga","year":"2007","journal-title":"Reprod. Toxicol."},{"issue":"3","key":"10.1016\/j.bcp.2019.01.024_b0110","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/pd.1948","article-title":"Trigonocephaly and valproate: a case report and review of literature","volume":"28","author":"Valentin","year":"2008","journal-title":"Prenat. Diagn."},{"key":"10.1016\/j.bcp.2019.01.024_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.reprotox.2016.06.006","article-title":"An international network (PlaNet) to evaluate a human placental testing platform for chemicals safety testing in pregnancy","author":"Brownbill","year":"2016","journal-title":"Reprod. Toxicol."},{"issue":"4","key":"10.1016\/j.bcp.2019.01.024_b0120","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1365-2125.2012.04332.x","article-title":"Prescribing without evidence \u2013 pregnancy","volume":"74","author":"Thomas","year":"2012","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2019.01.024_b0125","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0973-6883(12)60090-5","article-title":"A pharmacological profile of ribavirin and monitoring of its plasma concentration in chronic hepatitis C infection","volume":"2","author":"Naik","year":"2012","journal-title":"J. Clin. Exp. Hepatol."},{"issue":"6","key":"10.1016\/j.bcp.2019.01.024_b0130","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/bdd.2015","article-title":"The role of the equilibrative nucleoside transporter 1 on tissue and fetal distribution of ribavirin in the mouse","volume":"37","author":"Endres","year":"2016","journal-title":"Biopharm. Drug Dispos."},{"issue":"1","key":"10.1016\/j.bcp.2019.01.024_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2006.10.062","article-title":"Ribavirin uptake by cultured human choriocarcinoma (BeWo) cells and Xenopus laevis oocytes expressing recombinant plasma membrane human nucleoside transporters","volume":"557","author":"Yamamoto","year":"2007","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.bcp.2019.01.024_b0140","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/jac\/dkn421","article-title":"Usefulness of monitoring ribavirin plasma concentrations to improve treatment response in patients with chronic hepatitis C","volume":"62","author":"Morello","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"10.1016\/j.bcp.2019.01.024_b0145","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.tips.2009.10.001","article-title":"The complexities of antiretroviral drug-drug interactions: role of ABC and SLC transporters","volume":"31","author":"Kis","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.bcp.2019.01.024_b0150","doi-asserted-by":"crossref","first-page":"426","DOI":"10.2174\/157016109789043892","article-title":"Nucleoside transporter proteins","volume":"7","author":"Molina-Arcas","year":"2009","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.bcp.2019.01.024_b0155","doi-asserted-by":"crossref","DOI":"10.1124\/dmd.116.073304","article-title":"Multiple SLC and ABC transporters contribute to the placental transfer of entecavir","author":"Ma","year":"2017","journal-title":"Drug Metab. Dispos."},{"issue":"11","key":"10.1016\/j.bcp.2019.01.024_b0160","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1124\/dmd.118.083329","article-title":"Equilibrative nucleoside transporter 1 (ENT1, SLC29A1) facilitates transfer of the antiretroviral drug abacavir across the placenta","volume":"46","author":"Cerveny","year":"2018","journal-title":"Drug Metab. Dispos."},{"issue":"2","key":"10.1016\/j.bcp.2019.01.024_b0165","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF01871414","article-title":"Adenosine transport and nitrobenzylthioinosine binding in human placental membrane vesicles from brush-border and basal sides of the trophoblast","volume":"119","author":"Barros","year":"1991","journal-title":"J. Membr. Biol."},{"issue":"5","key":"10.1016\/j.bcp.2019.01.024_b0170","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0143-4004(05)80207-3","article-title":"Nucleoside transport by perfused human placenta","volume":"14","author":"Dancis","year":"1993","journal-title":"Placenta"},{"key":"10.1016\/j.bcp.2019.01.024_b0175","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.placenta.2017.10.011","article-title":"Role of nucleoside transporters in transplacental pharmacokinetics of nucleoside reverse transcriptase inhibitors zidovudine and emtricitabine","volume":"60","author":"Karbanova","year":"2017","journal-title":"Placenta"},{"issue":"5","key":"10.1016\/j.bcp.2019.01.024_b0180","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1124\/mol.111.071837","article-title":"Expression and distribution of nucleoside transporter proteins in the human syncytiotrophoblast","volume":"80","author":"Errasti-Murugarren","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2019.01.024_b0185","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fphar.2015.00013","article-title":"Nucleoside transporter proteins as biomarkers of drug responsiveness and drug targets","volume":"6","author":"Pastor-Anglada","year":"2015","journal-title":"Front. Pharmacol."},{"issue":"48","key":"10.1016\/j.bcp.2019.01.024_b0190","doi-asserted-by":"crossref","first-page":"45270","DOI":"10.1074\/jbc.M107169200","article-title":"Topology of a human equilibrative, nitrobenzylthioinosine (NBMPR)-sensitive nucleoside transporter (hENT1) implicated in the cellular uptake of adenosine and anti-cancer drugs","volume":"276","author":"Sundaram","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"45","key":"10.1016\/j.bcp.2019.01.024_b0195","doi-asserted-by":"crossref","first-page":"28423","DOI":"10.1074\/jbc.272.45.28423","article-title":"Molecular cloning and functional characterization of nitrobenzylthioinosine (NBMPR)-sensitive (es) and NBMPR-insensitive (ei) equilibrative nucleoside transporter proteins (rENT1 and rENT2) from rat tissues","volume":"272","author":"Yao","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2019.01.024_b0200","doi-asserted-by":"crossref","first-page":"606","DOI":"10.3389\/fphar.2018.00606","article-title":"Emerging roles of nucleoside transporters","volume":"9","author":"Pastor-Anglada","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2019.01.024_b0205","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3389\/fphar.2018.00627","article-title":"Who is who in adenosine transport","volume":"9","author":"Pastor-Anglada","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2019.01.024_b0210","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/cphy.c170039","article-title":"Intestinal nucleoside transporters: function, expression, and regulation","volume":"8","author":"Pastor-Anglada","year":"2018","journal-title":"Compr. Physiol."},{"issue":"5","key":"10.1016\/j.bcp.2019.01.024_b0215","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.placenta.2008.01.010","article-title":"Potential of various drugs to inhibit nucleoside uptake in rat syncytiotrophoblast cell line, TR-TBT 18d\u20131","volume":"29","author":"Chishu","year":"2008","journal-title":"Placenta"},{"issue":"5","key":"10.1016\/j.bcp.2019.01.024_b0220","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1007\/s12272-014-0437-y","article-title":"Contribution of CNT1 and ENT1 to ribavirin uptake in human hepatocytes","volume":"38","author":"Choi","year":"2015","journal-title":"Arch. Pharm. Res."},{"issue":"4","key":"10.1016\/j.bcp.2019.01.024_b0225","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2133\/dmpk.DMPK-11-RG-103","article-title":"Mechanism of nucleoside uptake in rat placenta and induction of placental CNT2 in experimental diabetes","volume":"27","author":"Nishimura","year":"2012","journal-title":"Drug Metab. Pharmacokinet."},{"issue":"4","key":"10.1016\/j.bcp.2019.01.024_b0230","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1517\/17425255.2015.1005073","article-title":"Regulation of drug transporter expression and function in the placenta","volume":"11","author":"Staud","year":"2015","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"9","key":"10.1016\/j.bcp.2019.01.024_b0235","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3109\/1061186X.2012.716847","article-title":"Pharmacotherapy in pregnancy; effect of ABC and SLC transporters on drug transport across the placenta and fetal drug exposure","volume":"20","author":"Staud","year":"2012","journal-title":"J. Drug Target."},{"issue":"3","key":"10.1016\/j.bcp.2019.01.024_b0240","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1128\/AAC.05762-11","article-title":"ENT1, a ribavirin transporter, plays a pivotal role in antiviral efficacy of ribavirin in a hepatitis C virus replication cell system","volume":"56","author":"Iikura","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.bcp.2019.01.024_b0245","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jhep.2010.01.011","article-title":"Characterization of ribavirin uptake systems in human hepatocytes","volume":"52","author":"Fukuchi","year":"2010","journal-title":"J. Hepatol."},{"issue":"9","key":"10.1016\/j.bcp.2019.01.024_b0250","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1021\/mp500263p","article-title":"Ribavirin uptake into human hepatocyte HHL5 cells is enhanced by interferon-alpha via up-regulation of the human concentrative nucleoside transporter (hCNT2)","volume":"11","author":"Pinilla-Macua","year":"2014","journal-title":"Mol. Pharmacol."},{"issue":"9","key":"10.1016\/j.bcp.2019.01.024_b0255","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1021\/mp200647a","article-title":"Role of the equilibrative and concentrative nucleoside transporters in the intestinal absorption of the nucleoside drug, ribavirin, in wild-type and Ent1(-\/-) mice","volume":"9","author":"Moss","year":"2012","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2019.01.024_b0260","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1124\/jpet.108.145854","article-title":"The role of the equilibrative nucleoside transporter 1 (ENT1) in transport and metabolism of ribavirin by human and wild-type or Ent1-\/- mouse erythrocytes","volume":"329","author":"Endres","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"9","key":"10.1016\/j.bcp.2019.01.024_b0265","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1002\/jps.22624","article-title":"Enhancement of zidovudine transfer to molt-4 cells, a human t-cell model, by dehydroepiandrosterone sulfate","volume":"100","author":"Nishimura","year":"2011","journal-title":"J. Pharm. Sci."},{"issue":"7","key":"10.1016\/j.bcp.2019.01.024_b0270","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1007\/s11095-008-9564-9","article-title":"Characterization of the mechanism of zidovudine uptake by rat conditionally immortalized syncytiotrophoblast cell line TR-TBT","volume":"25","author":"Sai","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.bcp.2019.01.024_b0275","unstructured":"Guide for the Care and Use of Laboratory Animals, in: N. A. Press (Ed.) National Research Council, Washington, DC, 1996."},{"key":"10.1016\/j.bcp.2019.01.024_b0280","unstructured":"European Convention for the Protection of Vertebrate Animals used for Experimental and Other Scientific Purposes, in: E. t. s. n. 123 (Ed.) Council of Europe, Strasbourg, France, 1986."},{"issue":"1","key":"10.1016\/j.bcp.2019.01.024_b0285","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/QAD.0000000000000112","article-title":"Interactions of tenofovir and tenofovir disoproxil fumarate with drug efflux transporters ABCB1, ABCG2, and ABCC2; role in transport across the placenta","volume":"28","author":"Neumanova","year":"2014","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.bcp.2019.01.024_b0290","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/bdd.1993","article-title":"Role of ABCB1, ABCG2, ABCC2 and ABCC5 transporters in placental passage of zidovudine","volume":"37","author":"Neumanova","year":"2016","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.bcp.2019.01.024_b0295","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.reprotox.2015.07.070","article-title":"Effect of drug efflux transporters on placental transport of antiretroviral agent abacavir","volume":"57","author":"Neumanova","year":"2015","journal-title":"Reprod. Toxicol."},{"issue":"10","key":"10.1016\/j.bcp.2019.01.024_b0300","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1128\/AAC.00671-07","article-title":"Effects of human immunodeficiency virus protease inhibitors on the intestinal absorption of tenofovir disoproxil fumarate in vitro","volume":"51","author":"Tong","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.bcp.2019.01.024_b0305","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1124\/dmd.107.017434","article-title":"In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system","volume":"36","author":"Feng","year":"2008","journal-title":"Drug Metab. Dispos."},{"issue":"2","key":"10.1016\/j.bcp.2019.01.024_b0310","first-page":"620","article-title":"Rational use of in vitro P-glycoprotein assays in drug discovery","volume":"299","author":"Polli","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"9","key":"10.1016\/j.bcp.2019.01.024_b0315","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1038\/nprot.2007.303","article-title":"Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers","volume":"2","author":"Hubatsch","year":"2007","journal-title":"Nat. Protoc."},{"issue":"11","key":"10.1016\/j.bcp.2019.01.024_b0320","doi-asserted-by":"crossref","first-page":"4413","DOI":"10.1002\/jps.21744","article-title":"Comparison of bidirectional lamivudine and zidovudine transport using MDCK, MDCK-MDR1, and Caco-2 cell monolayers","volume":"98","author":"de Souza","year":"2009","journal-title":"J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.bcp.2019.01.024_b0325","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ejpb.2012.07.020","article-title":"Comparison of brain capillary endothelial cell-based and epithelial (MDCK-MDR1, Caco-2, and VB-Caco-2) cell-based surrogate blood-brain barrier penetration models","volume":"82","author":"Hellinger","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"17","key":"10.1016\/j.bcp.2019.01.024_b0330","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1097\/00002030-200211220-00009","article-title":"Multidrug resistance protein 2 (MRP2) transports HIV protease inhibitors, and transport can be enhanced by other drugs","volume":"16","author":"Huisman","year":"2002","journal-title":"AIDS"},{"issue":"7","key":"10.1016\/j.bcp.2019.01.024_b0335","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1124\/dmd.106.014274","article-title":"Abcg2\/Bcrp1 mediates the polarized transport of antiretroviral nucleosides abacavir and zidovudine","volume":"35","author":"Pan","year":"2007","journal-title":"Drug Metab. Dispos."},{"issue":"6\u20137","key":"10.1016\/j.bcp.2019.01.024_b0340","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.placenta.2005.06.008","article-title":"MDR1 P-gp expression and activity in intact human placental tissue; upregulation by retroviral transduction","volume":"27","author":"Atkinson","year":"2006","journal-title":"Placenta"},{"key":"10.1016\/j.bcp.2019.01.024_b0345","first-page":"253","article-title":"In vitro methods for studying human placental amino acid transport placental villous fragments","volume":"122","author":"Greenwood","year":"2006","journal-title":"Methods Mol. Med."},{"issue":"2","key":"10.1016\/j.bcp.2019.01.024_b0350","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0005-2736(88)90475-0","article-title":"Purification and Na+ uptake by human placental microvillus membrane vesicles prepared by three different methods","volume":"945","author":"Glazier","year":"1988","journal-title":"Biochim. Biophys. Acta"},{"issue":"9","key":"10.1016\/j.bcp.2019.01.024_b0355","first-page":"3320","article-title":"Neutral amino acid uptake by the microvillous plasma membrane of the human placenta is inversely related to fetal size at birth in normal pregnancy","volume":"83","author":"Godfrey","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.bcp.2019.01.024_b0360","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1203\/00006450-199906000-00005","article-title":"System A amino acid transporter activity in human placental microvillous membrane vesicles in relation to various anthropometric measurements in appropriate and small for gestational age babies","volume":"45","author":"Harrington","year":"1999","journal-title":"Pediatr. Res."},{"issue":"6","key":"10.1016\/j.bcp.2019.01.024_b0365","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/0002-9378(94)90397-2","article-title":"Na+ transport, H+ concentration gradient dissipation, and system A amino acid transporter activity in purified microvillous plasma membrane isolated from first-trimester human placenta: comparison with the term microvillous membrane","volume":"171","author":"Mahendran","year":"1994","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.bcp.2019.01.024_b0370","first-page":"241","article-title":"In vitro methods for studying human placental amino acid transport: placental plasma membrane vesicles","volume":"122","author":"Glazier","year":"2006","journal-title":"Methods Mol. Med."},{"key":"10.1016\/j.bcp.2019.01.024_b0375","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.reprotox.2018.05.008","article-title":"Interactions of protease inhibitors atazanavir and ritonavir with ABCB1, ABCG2, and ABCC2 transporters: effect on transplacental disposition in rats","volume":"79","author":"Cerveny","year":"2018","journal-title":"Reprod. Toxicol."},{"issue":"1","key":"10.1016\/j.bcp.2019.01.024_b0380","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1124\/jpet.106.105023","article-title":"Expression and transport activity of breast cancer resistance protein (Bcrp\/Abcg2) in dually perfused rat placenta and HRP-1 cell line","volume":"319","author":"Staud","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.bcp.2019.01.024_b0385","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/jphp.12495","article-title":"Long-term administration of tenofovir or emtricitabine to pregnant rats; effect on Abcb1a, Abcb1b and Abcg2 expression in the placenta and in maternal and fetal organs","volume":"68","author":"Cerveny","year":"2016","journal-title":"J. Pharm. Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2019.01.024_b0390","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bpc.2009.12.012","article-title":"Kinetic study of anti-viral ribavirin uptake mediated by hCNT3 and hENT1 in Xenopus laevis oocytes","volume":"147","author":"Yamamoto","year":"2010","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.bcp.2019.01.024_b0395","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jpba.2017.07.003","article-title":"Current antiviral drugs and their analysis in biological materials \u2013 Part II: Antivirals against hepatitis and HIV viruses","volume":"147","author":"Novakova","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"3","key":"10.1016\/j.bcp.2019.01.024_b0400","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0890-6238(00)00071-X","article-title":"Functional expression of P-glycoprotein in primary cultures of human cytotrophoblasts and BeWo cells","volume":"14","author":"Utoguchi","year":"2000","journal-title":"Reprod. Toxicol."},{"issue":"7","key":"10.1016\/j.bcp.2019.01.024_b0405","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1021\/acs.molpharmaceut.8b00238","article-title":"Expression of concentrative nucleoside transporters (SLC28A) in the human placenta: effects of gestation age and prototype differentiation-affecting agents","volume":"15","author":"Jiraskova","year":"2018","journal-title":"Mol. Pharm."},{"issue":"10","key":"10.1016\/j.bcp.2019.01.024_b0410","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1023\/A:1026450326712","article-title":"Mechanisms of transport and structure-permeability relationship of sulfasalazine and its analogs in Caco-2 cell monolayers","volume":"17","author":"Liang","year":"2000","journal-title":"Pharm. Res."},{"key":"10.1016\/j.bcp.2019.01.024_b0415","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1741-7015-2-16","article-title":"Membrane transport of camptothecin: facilitation by human P-glycoprotein (ABCB1) and multidrug resistance protein 2 (ABCC2)","volume":"2","author":"Lalloo","year":"2004","journal-title":"BMC Med."},{"issue":"1","key":"10.1016\/j.bcp.2019.01.024_b0420","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/sj.bjp.0705921","article-title":"Nucleoside transporter subtype expression and function in rat skeletal muscle microvascular endothelial cells","volume":"143","author":"Archer","year":"2004","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2019.01.024_b0425","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1139\/y86-029","article-title":"Effects of temperature on the transport of nucleosides in guinea pig erythrocytes","volume":"64","author":"Jarvis","year":"1986","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"4","key":"10.1016\/j.bcp.2019.01.024_b0430","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2133\/dmpk.DMPK-09-RG-099","article-title":"Human erythrocyte nucleoside transporter ENT1 functions at ice-cold temperatures","volume":"25","author":"Takano","year":"2010","journal-title":"Drug Metab. Pharmacokinet."},{"issue":"8","key":"10.1016\/j.bcp.2019.01.024_b0435","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1038\/sj.bjp.0701775","article-title":"Ribavirin uptake by human erythrocytes and the involvement of nitrobenzylthioinosine-sensitive (es)-nucleoside transporters","volume":"123","author":"Jarvis","year":"1998","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2019.01.024_b0440","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/toxsci\/kfs160","article-title":"Synchronized activity of organic cation transporter 3 (Oct3\/Slc22a3) and multidrug and toxin extrusion 1 (Mate1\/Slc47a1) transporter in transplacental passage of MPP+ in rat","volume":"128","author":"Ahmadimoghaddam","year":"2012","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.bcp.2019.01.024_b0445","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.reprotox.2013.03.001","article-title":"Transfer of metformin across the rat placenta is mediated by organic cation transporter 3 (OCT3\/SLC22A3) and multidrug and toxin extrusion 1 (MATE1\/SLC47A1) protein","volume":"39","author":"Ahmadimoghaddam","year":"2013","journal-title":"Reprod. Toxicol."},{"issue":"9","key":"10.1016\/j.bcp.2019.01.024_b0450","doi-asserted-by":"crossref","first-page":"5563","DOI":"10.1128\/AAC.00648-16","article-title":"Role of ABC and solute carrier transporters in the placental transport of lamivudine","volume":"60","author":"Ceckova","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.bcp.2019.01.024_b0455","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1124\/jpet.109.160564","article-title":"Transplacental pharmacokinetics of glyburide, rhodamine 123, and BODIPY FL prazosin: effect of drug efflux transporters and lipid solubility","volume":"331","author":"Cygalova","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295219300309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295219300309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,11]],"date-time":"2022-09-11T09:00:38Z","timestamp":1662886838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295219300309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":91,"alternative-id":["S0006295219300309"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2019.01.024","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transport of ribavirin across the rat and human placental barrier: Roles of nucleoside and ATP-binding cassette drug efflux transporters","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2019.01.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}